Predictors of HVTN 503 MRK AD5 HIV-1 Gag/Pol/Nef Vaccine-Induced Immune Response

被引：0
|
作者：
Cerwensky, K. [1 ]
Laher, F. [1 ]
Otwombe, K. [1 ]
Churchyard, G. [2 ]
Bekker, L. [3 ]
Nchabeleng, M. [4 ]
Mlisana, K. [5 ]
Kublin, J. [6 ]
Gray, G. [1 ]
机构：
[1] Univ Witwatersrand, Soweto, South Africa
[2] Aurum Inst Hlth Res, Johannesburg, South Africa
[3] Univ Cape Town, ZA-7925 Cape Town, South Africa
[4] Univ Limpopo, Limpopo, South Africa
[5] Univ KwaZulu Natal, CAPRISA, Kwa Zulu, South Africa
[6] Fred Hutchinson Canc Res Ctr, Seattle, WA 98104 USA
来源：
AIDS RESEARCH AND HUMAN RETROVIRUSES | 2013年 / 29卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
引用
收藏
页码：A88 / A88
页数：1
相关论文
共 50 条
  • [11] Host Genetic Determinants of T Cell Responses to the MRKAd5 HIV-1 gag/pol/nef Vaccine in the Step Trial
    Fellay, Jacques
    Frahm, Nicole
    Shianna, Kevin V.
    Cirulli, Elizabeth T.
    Casimiro, Danilo R.
    Robertson, Michael N.
    Haynes, Barton F.
    Geraghty, Daniel E.
    McElrath, M. Juliana
    Goldstein, David B.
    JOURNAL OF INFECTIOUS DISEASES, 2011, 203 (06): : 773 - 779
  • [12] P19-32. HIV-1 vaccine design based on human vaccine trials to improve Gag, Pol, Nef and Env specific immune responses
    J Wild
    J Köstler
    S Bredl
    K Böckl
    K Kindsmüller
    R Wagner
    Retrovirology, 6
  • [13] HLA-Associated Immune Escape Pathways in HIV-1 Subtype B Gag, Pol and Nef Proteins
    Brumme, Zabrina L.
    John, Mina
    Carlson, Jonathan M.
    Brumme, Chanson J.
    Chan, Dennison
    Brockman, Mark A.
    Swenson, Luke C.
    Tao, Iris
    Szeto, Sharon
    Rosato, Pamela
    Sela, Jennifer
    Kadie, Carl M.
    Frahm, Nicole
    Brander, Christian
    Haas, David W.
    Riddler, Sharon A.
    Haubrich, Richard
    Walker, Bruce D.
    Harrigan, P. Richard
    Heckerman, David
    Mallal, Simon
    PLOS ONE, 2009, 4 (08):
  • [14] Recombinant adenovirus type 5 HIV gag/pol/nef vaccine in South Africa: unblinded, long-term follow-up of the phase 2h HVTN 503/Phambili study
    Gray, Glenda E.
    Moodie, Zoe
    Metch, Barbara
    Gilbert, Peter B.
    Bekker, Linda-Gail
    Churchyard, Gavin
    Nchabeleng, Maphoshane
    Mlisana, Koleka
    Laher, Fatima
    Roux, Surita
    Mngadi, Kathryn
    Innes, Craig
    Mathebula, Matsontso
    Allen, Mary
    McElrath, M. Julie
    Robertson, Michael
    Kublin, James
    Corey, Lawrence
    LANCET INFECTIOUS DISEASES, 2014, 14 (05): : 388 - 396
  • [15] Baseline Ad5 serostatus does not predict Ad5 HIV vaccine-induced expansion of adenovirus-specific CD4+ T cells
    Hutnick, Natalie A.
    Carnathan, Diane G.
    Dubey, Sheri A.
    Cox, Kara S.
    Kierstead, Lisa
    Ratcliffe, Sarah J.
    Robertson, Michael N.
    Casimiro, Danilo R.
    Ertl, Hildegund C. J.
    Betts, Michael R.
    NATURE MEDICINE, 2009, 15 (08) : 876 - 878
  • [16] Safety and immunogenicity of a replication-incompetent adenovirus type 5 HIV-1 clade B gag/pol/nef vaccine in healthy adults
    Priddy, Frances H.
    Brown, Deborah
    Kublin, James
    Monahan, Kathleen
    Wright, David P.
    Lalezari, Jacob
    Santiago, Steven
    Marmor, Michael
    Lally, Michelle
    Novak, Richard M.
    Brown, Stephen J.
    Kulkarni, Priya
    Dubey, Sheri A.
    Kierstead, Lisa S.
    Casimiro, Danilo R.
    Mogg, Robin
    DiNubile, Mark J.
    Shiver, John W.
    Leavitt, Randi Y.
    Robertson, Michael N.
    Mehrotra, Devan V.
    Quirk, Erin
    CLINICAL INFECTIOUS DISEASES, 2008, 46 (11) : 1769 - 1781
  • [17] Innate Immune Response Signatures to Ad5 (HVTN 071) and MVA (HVTN 205/908) Vectored Candidate HIV Vaccines Predict Induction of Adaptive Responses
    Andersen-Nissen, E.
    Zak, D. E.
    Duerr, A. C.
    Chang, J. T.
    Peterson, E. R.
    Krishnamurty, A. T.
    Hensley, T. R.
    Adams, D. J.
    Hamilton, M. K.
    Li, J.
    Sato, A.
    Morgan, C. A.
    Elizaga, M. L.
    DeRosa, S. C.
    Goepfert, P. A.
    Robinson, H. L.
    Aderem, A.
    McElrath, M. J.
    AIDS RESEARCH AND HUMAN RETROVIRUSES, 2011, 27 (10) : A5 - A5
  • [18] Modulation of Immune Responses to HIV-1 Env and Gag-Pol-Nef Antigens by Selective Deletion of a Poxvirus Gene
    Garcia-Arriaza, J.
    Esteban, M.
    AIDS RESEARCH AND HUMAN RETROVIRUSES, 2013, 29 (11) : A150 - A150
  • [19] Low-Dose Penile SIVmac251 Exposure of Rhesus Macaques Infected with Adenovirus Type 5 (Ad5) and Then Immunized with a Replication-Defective Ad5-Based SIV gag/pol/nef Vaccine Recapitulates the Results of the Phase IIb Step Trial of a Similar HIV-1 Vaccine
    Qureshi, Huma
    Ma, Zhong-Min
    Huang, Ying
    Hodge, Gregory
    Thomas, Michael A.
    DiPasquale, Janet
    DeSilva, Veronique
    Fritts, Linda
    Bett, Andrew J.
    Casimiro, Danilo R.
    Shiver, John W.
    Robert-Guroff, Marjorie
    Robertson, Michael N.
    McChesney, Michael B.
    Gilbert, Peter B.
    Miller, Christopher J.
    JOURNAL OF VIROLOGY, 2012, 86 (04) : 2239 - 2250
  • [20] Generation and immunogenicity of novel HIV/AIDS vaccine candidates targeting HIV-1 Env/Gag-Pol-Nef antigens of clade C
    Elena Gomez, Carmen
    Luis Najera, Jose
    Jimenez, Victoria
    Bieler, Kurt
    Wild, Jens
    Kostic, Linda
    Heidari, Shirin
    Chen, Margaret
    Frachette, Marie-Joelle
    Pantaleo, Giuseppe
    Wolf, Hans
    Liljestrom, Peter
    Wagner, Ralf
    Esteban, Mariano
    VACCINE, 2007, 25 (11) : 1969 - 1992
12345